On drug therapy for an HIV infection age model with cellular and immune delays
From MaRDI portal
Publication:6599378
Recommendations
- Drug therapy model with time delays for HIV infection with virus-to-cell and cell-to-cell transmissions
- Optimal drug therapy in a multi-pathways HIV-1 infection model with immune response delay
- Effect of delayed immune response on the dynamics of HIV infection under multidrug treatment
- The effects of delay and impulsive drug therapy in an HIV model with CTLs immune response
- Hopf bifurcation analysis of nonlinear HIV infection model and the effect of delayed immune response with drug therapies
Cites work
- scientific article; zbMATH DE number 7004012 (Why is no real title available?)
- A CTL-INCLUSIVE MATHEMATICAL MODEL FOR ANTIRETROVIRAL TREATMENT OF HIV INFECTION
- A delay-differential equation model of HIV infection of \(\text{CD}4^+\) T-cells
- A mathematical model for CTL effect on drug resistence during antiretroviral treatment of HIV infection
- A mathematical model for HIV treatment with time-varying antiretroviral therapy
- A mathematical model for the emergence of HIV drug resistance during periodic bang-bang type antiretroviral treatment
- A mathematical model of HTLV-I infection with two time delays
- A model incorporating combined RTIs and PIs therapy during early HIV-1 infection
- A model of HIV-1 infection with two time delays: mathematical analysis and comparison with patient data
- A model of HIV-1 pathogenesis that includes an intracellular delay
- A parameter sensitivity methodology in the context of HIV delay equation models
- Analysis of stability and Hopf bifurcation for HIV-1 dynamics with PI and three intracellular delays
- Drug therapy model with time delays for HIV infection with virus-to-cell and cell-to-cell transmissions
- Dynamics of a HIV-1 infection model with cell-mediated immune response and intracellular delay
- Estimating kinetic parameters from HIV primary infection data through the eyes of three different mathematical models
- Global dynamics of an in-host viral model with intracellular delay
- Global stability of an HIV-1 model with distributed intracellular delays and a combination therapy
- HIV-1 infection and low steady state viral loads
- Mathematical Analysis of HIV-1 Dynamics in Vivo
- Modeling HIV-1 virus dynamics with both virus-to-cell infection and cell-to-cell transmission
- Modeling pharmacodynamics on HIV latent infection: choice of drugs is key to successful cure via early therapy
- Periodic oscillations in leukopoiesis models with two delays
- Stability analysis in delayed within-host viral dynamics with both viral and cellular infections
Cited in
(2)
This page was built for publication: On drug therapy for an HIV infection age model with cellular and immune delays
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6599378)